Supplementing lactating women with flaxseed oil does not increase docosahexaenoic acid in their milk

Open Access
Publisher Website
Google Scholar
Abstract
Background: Flaxseed oil is a rich source of 18:3n−3 (α-linolenic acid, or ALA), which is ultimately converted to 22:6n−3 (docosahexaenoic acid, or DHA), a fatty acid important for the development of the infant brain and retina. Objective: The objective of this study was to determine the effect of flaxseed oil supplementation on the breast-milk, plasma, and erythrocyte contents of DHA and other n−3 fatty acids in lactating women. Design: Seven women took 20 g flaxseed oil (10.7 g ALA) daily for 4 wk. Breast-milk and blood samples were collected weekly before, during, and after supplementation and were analyzed for fatty acid composition. Results: Breast milk, plasma, and erythrocyte ALA increased significantly over time (P < 0.001) and after 2 and 4 wk of supplementation (P < 0.05). Over time, 20:5n−3 (eicosapentaenoic acid, or EPA) increased significantly in breast milk (P = 0.004) and in plasma (P < 0.001). In addition, plasma EPA increased significantly (P < 0.05) after 2 and 4 wk of supplementation. There were significant increases over time in breast-milk 22:5n−3 (docosapentaenoic acid, or DPA) (P < 0.02), plasma DPA (P < 0.001), and erythrocyte DPA (P < 0.01). No significant changes were observed in breast-milk, plasma, or erythrocyte DHA contents after flaxseed oil supplementation. Conclusions: Dietary flaxseed oil increased the breast-milk, plasma, and erythrocyte contents of the n−3 fatty acids ALA, EPA, and DPA but had no effect on breast-milk, plasma, or erythrocyte DHA contents.